Skip to main content

Find Clinical Trials

Home
Conditions
Hepadnaviridae Infections

Clinical trial condition

Hepadnaviridae Infections

Explore clinical trials studying Hepadnaviridae Infections. Study availability and eligibility vary by location and protocol.

1,149 public trials 113 recruiting studies

Refine in advanced search Browse all conditions

Hepadnaviridae Infections trial results

Completed

Study to Asses DTPw-HBV/Hib at 15-18 Months (m) and Mencevax™ ACW at 24 to 30 m in Primed Subjects

NCT00317109

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Blood-Borne Infections, +23 more
Locations: GSK Investigational Site Brits, South Africa

GSK Investigational Site Ga-Rankuwa, South Africa

GSK Investigational Site Rooihuiskraal, South Africa

View Trial Details

Completed

This Study Aims to Determine the Long-term Persistence of Antibodies Against Hepatitis B and to Evaluate the Immunogenicity and Safety of Hepatitis B Vaccine in Adolescents Vaccinated in Infancy With Infanrix™ Hexa

NCT02052661

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: GSK Investigational Site Kehl, Baden-Wurttemberg, Germany

GSK Investigational Site Tuttlingen, Baden-Wurttemberg, Germany

GSK Investigational Site Bindlach, Bavaria, Germany

GSK Investigational Site Goch, North Rhine-Westphalia, Germany

View Trial Details

Completed

A Study of Treatment With RO6864018 in Virologically Suppressed Participants With Chronic Hepatitis B Virus (HBV) Infection

NCT02391805

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Queen Mary Hospital Hong Kong

Prince of Wales Hospital; Special Medical Clinic N.T., Hong Kong

Hospital Ampang Ampang, Malaysia

Hospital Selayang; Medicine Batu Caves, Malaysia

View all 14 locations

View Trial Details

Completed

Immune Response & Safety of GSK Biologicals' Mencevax™ ACWY in Subjects Primed in the DTPW-HBV=HIB-MENAC-TT-011 Study

NCT00291343

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Blood-Borne Infections, +23 more
Locations: GSK Investigational Site Manila, Philippines

GSK Investigational Site Sampaloc, Manila, Philippines

View Trial Details

Completed

Phase III, Study to Evaluate the Efficacy of Two Different HBV Vaccination Schemes in Patients With Hepatic Cirrhosis

NCT01884415

Conditions: Awaiting Organ Transplant, Blood-Borne Infections, Cirrhosis, +13 more
Locations: Virgen del Rocío Hospital Seville, Spain

View Trial Details

Completed

Study of Therapeutic Vaccination With Intensified Schedule Plus Pegasys Dual Therapy on Chronic Hepatitis B Infection

NCT02097004

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Seoul National University Seoul, South Korea

View Trial Details

Completed

Combination Therapy With Interferon Plus Interleukin 2 and Hepatitis B Vaccine in Chronic Hepatitis B Patients

NCT02360592

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Anhui Provincial Hospital Hefei, Anhui, China

BeiJing YouAn Hospital, Capital Medical University Beijing, Beijing Municipality, China

First Hospital, Beijing University Beijing, Beijing Municipality, China

People'S Hospital Under Beijing University Beijing, Beijing Municipality, China

View Trial Details

Completed

Pilot Study: Gene Expression Profiling of Immune Response to HBV Vaccination in Healthy Volunteers

NCT02055365

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: The Rockefeller University New York, United States

View Trial Details

Completed

Optimizing HBV Management During Anti-CD20 Antibodies

NCT03155984

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +10 more
Locations: The University of Hong Kong Hong Kong

View Trial Details

Completed

A Study of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus (HBV)-Infection

NCT00423891

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: University of California, San Francisco San Francisco, California, United States

Connecticut Children'S Medical Center Hartford, Connecticut, United States

University Of Florida Gainesville, Florida, United States

Johns Hopkins School Of Medicine Baltimore, Maryland, United States

View all 19 locations

View Trial Details